Guangdong Kanghua Healthcare Co., Ltd.
HKEX:3689.HK
2.17 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,041.858 | 1,845.633 | 1,953.944 | 1,745.023 | 1,955.525 | 1,639.287 | 1,389.169 | 1,240.39 | 1,063.702 | 985.108 | 858.874 |
| Cost of Revenue
| 1,677.488 | 1,584.283 | 1,601.196 | 1,481.868 | 1,566.106 | 1,280.383 | 1,058.293 | 943.479 | 824.29 | 761.424 | 669.778 |
| Gross Profit
| 364.37 | 261.35 | 352.748 | 263.155 | 389.419 | 358.904 | 330.876 | 296.911 | 239.412 | 223.684 | 189.096 |
| Gross Profit Ratio
| 0.178 | 0.142 | 0.181 | 0.151 | 0.199 | 0.219 | 0.238 | 0.239 | 0.225 | 0.227 | 0.22 |
| Reseach & Development Expenses
| 0 | 1.096 | 0.835 | 1.595 | 1.03 | 0.62 | 1.094 | 0.745 | 0.709 | 0.726 | 0.742 |
| General & Administrative Expenses
| 242.391 | 228.323 | 225.223 | 227.774 | 232.282 | 185.178 | 126.994 | 109.042 | 83.657 | 79.855 | 74.365 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 242.391 | 228.323 | 225.223 | 227.774 | 232.282 | 185.178 | 126.994 | 109.042 | 83.657 | 79.855 | 74.365 |
| Other Expenses
| 0 | -5.73 | -11.186 | -6.345 | -0.143 | 13.248 | 7.003 | -6.175 | 3.694 | 4.391 | 2.748 |
| Operating Expenses
| 225.688 | 222.593 | 214.037 | 221.429 | 232.139 | 187.198 | 124.562 | 105.705 | 78.674 | 74.041 | 66.39 |
| Operating Income
| 119.211 | 73.111 | 139.74 | -22.163 | 113.776 | 171.706 | 206.314 | 191.206 | 160.738 | 149.643 | 122.706 |
| Operating Income Ratio
| 0.058 | 0.04 | 0.072 | -0.013 | 0.058 | 0.105 | 0.149 | 0.154 | 0.151 | 0.152 | 0.143 |
| Total Other Income Expenses Net
| 34.218 | 41.165 | -19.171 | -26.089 | -40.391 | 50.048 | 15.275 | 10.104 | -11.92 | -14.431 | 2.036 |
| Income Before Tax
| 153.429 | 69.309 | 129.209 | -26.089 | 117.485 | 221.754 | 218.076 | 198.473 | 148.818 | 135.212 | 124.742 |
| Income Before Tax Ratio
| 0.075 | 0.038 | 0.066 | -0.015 | 0.06 | 0.135 | 0.157 | 0.16 | 0.14 | 0.137 | 0.145 |
| Income Tax Expense
| 62.406 | 41.573 | 62.284 | 23.967 | 68.797 | 60.482 | 56.937 | 52.786 | 29.854 | 27.445 | 15.629 |
| Net Income
| 121.062 | 27.736 | 66.925 | -50.056 | 48.688 | 167.943 | 156.592 | 141.26 | 118.847 | 102.237 | 107.309 |
| Net Income Ratio
| 0.059 | 0.015 | 0.034 | -0.029 | 0.025 | 0.102 | 0.113 | 0.114 | 0.112 | 0.104 | 0.125 |
| EPS
| 0.36 | 0.083 | 0.2 | -0.15 | 0.15 | 0.5 | 0.47 | 0.54 | 0.48 | 0.41 | 0.43 |
| EPS Diluted
| 0.36 | 0.083 | 0.2 | -0.15 | 0.15 | 0.5 | 0.47 | 0.54 | 0.48 | 0.41 | 0.43 |
| EBITDA
| 308.563 | 233.793 | 298.464 | 138.794 | 257.33 | 269.743 | 253.482 | 229.131 | 193.284 | 179.521 | 153.191 |
| EBITDA Ratio
| 0.151 | 0.121 | 0.148 | 0.069 | 0.121 | 0.165 | 0.195 | 0.2 | 0.242 | 0.256 | 0.257 |